Clinical Research and GCP Update

57

How did you reduce risks to trial participants?

57

58

Risks to trial participants

• Stopping visits to trial site may affect participant safety • Concomitant medications that may be needed to combat illness • Trial patients taking immuno-suppressants, ‘at risk patients’ • Distribution of IMP/treatments to patients at home • Oversight and supervision of trial participants • Help and advice provision

58

© Brookwood Global (Canary Ltd) 2021

29